Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$67.99 - $132.89 $949,344 - $1.86 Million
-13,963 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $51,461 - $71,219
-547 Reduced 3.77%
13,963 $7.14 Million
Q4 2021

Feb 04, 2022

SELL
$129.87 - $162.82 $40,779 - $51,125
-314 Reduced 2.12%
14,510 $7.79 Million
Q3 2021

Nov 12, 2021

SELL
$106.71 - $143.18 $45,671 - $61,281
-428 Reduced 2.81%
14,824 $8.11 Million
Q2 2021

Aug 13, 2021

SELL
$80.99 - $107.93 $60,094 - $80,084
-742 Reduced 4.64%
15,252 $6.51 Million
Q1 2021

May 14, 2021

SELL
$84.79 - $104.74 $9,496 - $11,730
-112 Reduced 0.7%
15,994 $5.75 Million
Q4 2020

Feb 16, 2021

SELL
$78.0 - $104.5 $14,508 - $19,437
-186 Reduced 1.14%
16,106 $5.96 Million
Q3 2020

Nov 04, 2020

SELL
$95.51 - $112.95 $669,907 - $792,231
-7,014 Reduced 30.1%
16,292 $6.72 Million
Q2 2020

Jul 31, 2020

BUY
$62.68 - $105.34 $1.23 Million - $2.07 Million
19,652 Added 537.82%
23,306 $9.45 Million
Q1 2020

May 08, 2020

BUY
$47.79 - $75.63 $174,624 - $276,352
3,654 New
3,654 $984,000
Q2 2019

Aug 13, 2019

SELL
$27.84 - $38.92 $73,608 - $102,904
-2,644 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$28.07 - $38.18 $332 Million - $452 Million
-11,832,000 Reduced 99.98%
2,644 $315,000
Q1 2019

May 13, 2019

BUY
$28.07 - $38.18 $331 Million - $451 Million
11,803,828 Added 38304.22%
11,834,644 $12.7 Million
Q4 2018

Feb 14, 2019

BUY
$26.99 - $37.37 $831,723 - $1.15 Million
30,816 New
30,816 $3.69 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Mackay Shields LLC Portfolio

Follow Mackay Shields LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.